Russia's Pharmstandard Said Weighing Sale Of $2.5 Billion OTC Business
This article was originally published in PharmAsia News
Executive Summary
Russia's largest drug maker, OAO Pharmstandard is reported by sources to consider selling its over-the-counter drugs business valued at about $2.5 billion.